WebApr 5, 2024 · Dyne Therapeutics, Inc. Common Stock (DYN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. WebReal time Dyne Therapeutics (DYN) stock price quote, stock graph, news & analysis.
Did you know?
WebDyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle ... WebApr 11, 2024 · Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Rating) have earned an average rating of "Moderate Buy" from the seven ratings firms that are …
WebDYN (Dyne Therapeutics) Market Cap as of today (January 08, 2024) is $606.76 Mil. Market Cap explanation, calculation, historical data and more DYN (Dyne … WebApr 12, 2024 · Market Cap Chart Since the IPO on September 17, 2024, Dyne Therapeutics, Inc.'s market cap has decreased from $790.90M to $480.56M, a decrease of -39.24%. That is a compound annual growth rate of -17.66%.
WebApr 6, 2024 · 91,5%. More Financials. Company. Dyne Therapeutics Inc. is a muscle disease company. The Company is focused on advancing therapeutics for patients with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. WebOur data points out that Dyne Therapeutics, Inc. (DYN) is ranked #5407 out of 13000 companies on February - 2024. DYN's Market Capitalization is $700 million and the …
WebDyne Therapeutics Inc Working Capital Per Revenue on the trailing twelve month basis from the forth quarter 2024 to forth quarter 2024, Trends and Ranking, Fundamental Ratios - CSIMarket Company Name, Ticker, Suppliers, else..
WebMar 29, 2024 · Get a real-time Dyne Therapeutics, Inc. (DYN) stock price quote with breaking news, financials, statistics, charts and more. ... Market Cap: 628.17M: Revenue (ttm) n/a: Net Income (ttm)-168.10M: Shares Out 56.34M: EPS (ttm)-3.23: PE Ratio ... Chardan Initiates Coverage On These 'Intriguing Small-Cap Stories" Chardan Research … chinese restaurant loveland coWebDyne Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares. grandstream phone self defined city codeWebMar 13, 2024 · About Market Cap. As of the previous market close, Dyne Therapeutics, Inc. has a market cap of $737.47M, which represents its share price of $13.09 multiplied … chinese restaurant main street hackensackWebDyne Therapeutics, Inc. Analyst Report: Xcel Energy Inc. Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Discover historical prices for DYN stock on Yahoo Finance. View daily, weekly or … Get the detailed quarterly/annual income statement for Dyne Therapeutics, Inc. … View the basic DYN option chain and compare options of Dyne Therapeutics, … Find out the direct holders, institutional holders and mutual fund holders for … Dyne Therapeutics, Inc. 1560 Trapelo Road Waltham, MA 02451 United States 781 … See Dyne Therapeutics, Inc. (DYN) stock analyst estimates, including earnings … Find out all the key statistics for Dyne Therapeutics, Inc. (DYN), including … Dyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, … See Dyne Therapeutics, Inc. (DYN) Environment, Social and Governance … Find the latest Dyne Therapeutics, Inc. (DYN) stock quote, history, news and … grandstream phone singaporeWebJan 27, 2024 · With a market capitalization of US$963m, Dyne Therapeutics is a decent size, so it is probably on the radar of institutional investors. In the chart below, we can see that institutions own shares ... grandstream phones gxp2020WebDyne Therapeutics (DYN) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Market Cap. $495.76M. Enterprise Value $263.49M. Total Cash (Recent Filing) $256.01M. Total Debt (Recent Filing) $30.48M. Price to Earnings (P/E)-2.7. Beta 0.93. Next … chinese restaurant manahawkin njWebJan 18, 2024 · Dyne Therapeutics had its IPO a year ago. The clinical-stage biotech has $407.5 million in cash but no revenue. The company specializes in treating serious … grandstream phones how to transfer calls